Clinical Trial Update: Treatment of Non-responding to Conventional Therapy Inoperable Liver Cancers by in Situ Introduction of ImDendrim [NA]

View source ↗

Summary

This document provides an update on a clinical trial evaluating ImDendrim delivered in situ for non-responding, inoperable liver cancers, focusing on efficacy a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• ImDendrim

Snippet

Sponsor: French Association for the Advancement Medical Research | Conditions: Efficacy and Safety | NA | Status: UNKNOWN